Evidence map›Paper›PMID 39671468›Full record

ArticleScience immunology2024

Asparagine availability controls germinal center B cell homeostasis.

Yavuz F Yazicioglu, Eros Marin, Hana F Andrew, Karolina Bentkowska, Julia C Johnstone, Robert Mitchell, Zhi Yi Wong, Kristina Zec, Joannah Fergusson, Mariana Borsa and 11 more

Abstract read
In one paragraph

Article in Science immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. A guide to B cell metabolism.Nature reviews. Immunology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. RNA binding proteinScience advances · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Yavuz F YaziciogluKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-3731-9333
Eros MarinKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Hana F AndrewKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0009-0006-3954-8630
Karolina BentkowskaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Julia C JohnstoneKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0009-0003-5856-9283
Robert MitchellKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Zhi Yi WongKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-1452-1387
Kristina ZecKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-1005-2368
Joannah FergussonKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0001-9223-1209
Mariana BorsaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-1519-2597
Iwan G A RazaKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Moustafa AttarKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-4116-1276
Mohammad AliNuffield Department of Medicine Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-0170-7182
Barbara KronsteinerNuffield Department of Medicine Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-0867-2867
Izadora L FurlaniMetabolomics STP, Francis Crick Institute, London NW1 1AT, UK.ORCID 0000-0002-2745-7612
James I MacRaeMetabolomics STP, Francis Crick Institute, London NW1 1AT, UK.ORCID 0000-0002-1464-8583
Michael J DevineMitochondrial Neurobiology Laboratory, Francis Crick Institute, London NW1 1AT, UK; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.ORCID 0000-0001-6076-3382
Mark ColesKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0001-8079-9358
Christopher D BuckleyKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0001-6924-6402
Susanna J DunachieNuffield Department of Medicine Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-5665-6293
Alexander J ClarkeKennedy Institute of Rheumatology, University of Oxford, Oxford, UK.ORCID 0000-0003-2846-7860

Funding

Peptide Growth Factors That Regulate Tumor ProliferationZ01SC000173 · SC · CLINICAL SCIENCES · PI CUTTITTA, FRANK · 1996 to 2005
–
Cancer Research UK CC2206Intramural NIH HHS Z01 SC000173Wellcome Trust 203141Wellcome Trust CC2206
6 · The paper itself

Abstract

The rapid proliferation of germinal center (GC) B cells requires metabolic reprogramming to meet energy demands, yet these metabolic processes are poorly understood. By integrating metabolomic and transcriptomic profiling of GC B cells, we identified that asparagine (Asn) metabolism was highly up-regulated and essential for B cell function. Asparagine synthetase (ASNS) was up-regulated after B cell activation through the integrated stress response sensor GCN2. Conditional deletion of

Indexed as

AsparagineB-LymphocytesGerminal CenterHomeostasisAnimalsAspartate-Ammonia LigaseMiceMice, Inbred C57BLMice, KnockoutAsparagineAspartate-Ammonia Ligase

Identifiers

PMID39671468
PMCPMC7617476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.